CClinicalTrials.gg
WithdrawnNCT05974254Updated Mar 3, 2026

Auricular Acupuncture As Part Of A Multimodal Regimen After Distal Radius Open Reduction and Internal Fixation

An interventional study of Acupuncture in Radius Fracture Distal and Pain, Postoperative, sponsored by Baylor College of Medicine. Withdrawn at 1 site in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-03-03.

Sponsored by Baylor College of Medicine · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Unable to support start of study. PI left the institution. No patients recruited.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

This randomized controlled trial will test the hypothesis that patients receiving an intraoperative auricular acupuncture protocol will require less postoperative opioid analgesic use compared to those who do not receive acupuncture in the setting of a multimodal analgesic protocol for patients receiving surgery to repair distal radius fractures at a Level 1 trauma center under brachial plexus anesthesia with sedation.

02

Conditions studied

  • Radius Fracture Distal
  • Pain, Postoperative
03

In context

Wrist Fractures

323 studies on the registry are indexed under Wrist Fractures; 71 are open to participants now.

Browse Wrist Fractures studies →

Lead sponsor

Baylor College of Medicine is the lead sponsor of 734 studies on the registry; 110 are open to participants now.

Of its 83 completed or terminated interventional studies of FDA-regulated products, 44 (53%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient ages 18-64
  • American Society of Anesthesiologists Physical Status 1, 2, or 3
  • Patients scheduled to undergo distal radius ORIF under brachial plexus nerve block

Exclusion criteria

Exclusion Criteria:

  • Renal dysfunction (Serum Cr > 1.2) - excluded due to potential for altered metabolism of anesthetic and perioperative medications
  • Allergy to any of the standard anesthetic agents
  • Patient inability to properly communicate with investigators
  • Patient or surgeon refusal
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Electroauricular acupuncture

    Immediately after Level 2 sedation is achieved, an enhanced auricular trauma protocol (ATP) will be administered on the ear ipsilateral to the operative side at 8 ear points (Hypothalamus, Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Shen Men, Insula, Vagus) as described by Cheng (2022). The original ATP was described by Helms (2011). Seirin L 0.2 x 30 mm needles will be placed at Hypothalamus and Shen Men points. Seirin J 0.18 x 15 mm needles will be placed at Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Vagus, and Insula points. Electrostimulation using an ITO ES 130 microstimulator at 30 HZ with Level 4 intensity, will be applied with the positive lead (red) on Hypothalamus and negative lead (black) at Shen Men for 60 minutes. All needles will be removed 1 hour after insertion.

    Device: Acupuncture

  • No intervention
    No acupuncture

    No acupuncture treatment given

Interventions

  • DeviceAcupuncture

    Electroacupuncture

06

What researchers measure

Primary outcomes

  1. Total opioid analgesic use for 14 days after surgery

    Total opioid given in hospital and taken at home, converted to oral morphine equivalents

    Time frame: 14 days

Secondary outcomes

  1. Pain scores

    Pain scores in PACU and at the 7 and 14 day mark post surgery

    Time frame: 14 days

  2. Incidence of side effects associated with opioid use

    PONV, pruritus, headache, constipation, urinary retention, fatigue, difficulty with concentration, drowsiness, lightheadedness, dry mouth

    Time frame: 14 days

07

Study locations

1 site
  • Ben Taub Hospital
    Houston, Texas 77030, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05974254
Lead sponsor
Baylor College of Medicine
Responsible party
Jaime Ortiz (Professor of Anesthesiology, Baylor College of Medicine) — Principal investigator
First posted
Aug 3, 2023
Start date
Oct 9, 2023 (estimated)
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Mar 3, 2026

Study contacts

Jaime Ortiz, MD, MBA
principal investigator · Baylor College of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion